| Stage | PAY | % of rev | ECG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $372M | 100.00% | $1.2B | 100.00% | ECG ×3.31 |
| Gross profit | $94M | 25.21% | $183M | 14.85% | PAY +10.4pp |
| Operating income | $34M | 9.01% | $112M | 9.08% | ECG +0.1pp |
| Pre-tax income | $37M | 9.90% | $110M | 8.93% | PAY +1.0pp |
| Net income | $27M | 7.38% | $84M | 6.81% | PAY +0.6pp |
| Stage | PAY | ECG | Gap · A − B |
|---|---|---|---|
| Revenue | $372M100.00% | $1.2B100.00% | ECG ×3.31 |
| Gross profit | 25.21%$94M | 14.85%$183M | PAY +10.4pp |
| Operating income | 9.01%$34M | 9.08%$112M | ECG +0.1pp |
| Pre-tax income | 9.90%$37M | 8.93%$110M | PAY +1.0pp |
| Net income |
| 7.38%$27M |
| 6.81%$84M |
| PAY +0.6pp |
No shared counterparties.